Ixazomib Citrate is an oral proteasome inhibitor used in the treatment of multiple myeloma, a type of blood cancer. It works by inhibiting the activity of proteasomes, which are protein complexes that play a critical role in maintaining cell function by degrading damaged or unneeded proteins. By inhibiting proteasomes, Ixazomib Citrate causes an accumulation of proteins within cancer cells,...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Russian
Romaian